465547-58-4

Basic information

• Product Name: Carbamic acid, [4-[[1,4-dihydro-1,4-dioxo-3-(1-pyrrolidinyl)-2-naphthalenyl]amino]phenyl ]-, methyl ester
• CAS NO: 465547-58-4
• Molecular Formula: C22H21N3O4
• Molecular Weight: 391.426
• Mol File: 465547-58-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [4-[[1,4-dihydro-1,4-dioxo-3-(1-pyrrolidinyl)-2-naphthalenyl]amino]phenyl ]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [4-[[1,4-dihydro-1,4-dioxo-3-(1-pyrrolidinyl)-2-naphthalenyl]amino]phenyl ]-, methyl ester(465547-58-4)
• EPA Substance Registry System: Carbamic acid, [4-[[1,4-dihydro-1,4-dioxo-3-(1-pyrrolidinyl)-2-naphthalenyl]amino]phenyl ]-, methyl ester(465547-58-4)

Safety Data

• Hazardous Substances Data: 465547-58-4(Hazardous Substances Data)

Upstream product

• 123-75-1 pyrrolidine 
• 92796-77-5 2-(4-amino-anilino)-3-chloro-[1,4]naphthoquinone 
• 79-22-1 methyl chloroformate 

Relevant articles and documents

Identification of compounds for the treatment or prevention of proliferative diseases

The invention features compounds for the treatment of cancer and other proliferative diseases. These compounds were identified in screening assays that contact candidate compounds with a cell containing a nucleic acid that includes a HER2 regulatory element and a reporter sequence. The invention further features compounds structurally related to those identified by the screening assays. Finally, the invention features methods of treating or preventing a proliferative disease using the compounds of the invention.